Table 1.
Clinical characteristics of patients according to engraftment status.
| Characteristics | Total (%) | Engrafted (%) | Failed (%) | p-Value |
|---|---|---|---|---|
| Number of patients | 114 (100) | 20 (17.5) | 94 (82.5) | |
| Age at collection (years) | 49.60 ± 11.60 | 46.40 ± 13.69 | 49.94 ± 10.90 | 0.175 (b) |
| Tissue source | ||||
| Surgery | 57 (50.0) | 14 (24.6) | 43 (75.4) | 0.085 (c) |
| Biopsy | 57 (50.0) | 6 (10.5) | 51 (89.5) | |
| Stage | ||||
| I | 9 (7.9) | 1 (11.1) | 8 (88.9) | 0.039 (d) |
| II | 47 (41.2) | 5 (10.6) | 42(89.4) | |
| III | 48 (42.1) | 9 (18.7) | 39(81.3) | |
| IV | 10 (8.8) | 5 (50.0) | 5 (50.0) | |
| Chemotherapy resistance (a) | ||||
| Yes | 28 (24.6) | 13 (46.4) | 15 (53.6) | <0.001 (d) |
| No | 86 (74.6) | 7 (8.1) | 79 (91.9) |
Values are presented as numbers (%) or means ± standard deviation. (a) Chemotherapy resistance is defined as patients with progression on chemotherapy or recurrence within one year after adjuvant chemotherapy. (b) Wilcoxon rank-sum test. (c) Pearson chi-square test. (d) Fisher’s exact test.